Physician profile
Michael Bode
NPI 1477831188
$57,570.32
in general payments reported to CMS, 2019-2025
27 companies · $657 in 2025
The $657 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $29K · 2021: $25K · 2022: $399 · 2023: $1,040 · 2024: $902 · 2025: $657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $40,425.93 | 2020-2023 | Lux-Dx Insertable Cardiac Monitor, Avvigo Guidance System |
| Abbott Laboratories | $14,364.30 | 2019-2025 | Ensite, Assurity, Gallant |
| Abiomed | $531.17 | 2021-2025 | Impella |
| Inari Medical, INC. | $347.45 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $271.73 | 2021-2023 | Cobalt Dr Mri Surescan, Onyx Frontier |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $252.60 | 2023-2025 | Lifevest |
| Shockwave Medical, INC | $211.67 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $188.53 | 2020 | |
| Medtronic Vascular, INC. | $136.09 | 2020 | |
| Cardiva Medical, INC. | $125.00 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cardiovascular Systems INC. | $119.38 | 2019 | |
| Cardinal Health 200 LLC | $91.80 | 2019 | |
| Angiodynamics, INC. | $73.93 | 2025 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $72.19 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $51.28 | 2023-2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $44.40 | 2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $39.26 | 2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $28.16 | 2023-2025 | Verquvo, Steglatro |
| Lantheus Medical Imaging, INC. | $26.82 | 2022 | |
| Cvrx, INC. | $25.68 | 2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $24.46 | 2023 | |
| Impulse Dynamics (USA) INC. | $24.34 | 2023 | Optimizer |
| Inspire Medical Systems, INC. | $23.01 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, Ltd. | $20.97 | 2023 | Arcalyst |
| Penumbra, INC. | $19.81 | 2024 | Indigo System |
| Janssen Pharmaceuticals, INC | $17.68 | 2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $12.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.